Special Issue "Rheumatoid Arthritis and Other Inflammatory Diseases: From Pathogenesis through Therapeutic Targets to Personalized Medicine"
Deadline for manuscript submissions: 31 January 2021.
Interests: autoimmunity; genetics; epigenetics; personalized medicine; T cells; Toll-like receptors
Arthritis, as well as inflammation, is a common health problem in the global population affecting millions of people, and a leading cause of disability. Every day, patients with rheumatoid arthritis (RA) or other inflammatory diseases take drugs without efficient results. Early diagnosis of these patients is significant insomuch as primary treatment can be started better. Appropriate selection of convenient and safe therapy may be an effective tool not only to relieve symptoms of the disease but also to improve the length and quality of life, and for the remission of the disease. The reason for this variability between individuals is unclear, but it leads to studies identifying biomarkers predictive of the treatment response. The use of traditional markers that have been clinically useful in the context of personalized medicine is insufficient. Therefore, an individual approach to each patient is crucial. There is a huge demand for reliable biomarkers associated with response to biological treatments to improve reactivity and reduce treatment costs. Pharmacogenetic and pharmacogenomic studies, which help to determine the genetic profile of individual patients, may bring us closer to personalized medicine.
Dr. Agnieszka Paradowska‑Gorycka
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.